13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001727492-23-000011
Total Value
$217.8M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORP | LQDA | 9,243,627 | $58.6M | 26.91% |
| 2 | ALIMERA SCIENCES INC | 016259202 | 16,835,154 | $52.2M | 23.97% |
| 3 | INTERCEPT PHARMACEUTICALS INC | INTR | 1,200,000 | $22.2M | 10.22% |
| 4 | STANDARD BIOTOOLS INC | LAB | 7,622,413 | $22.1M | 10.15% |
| 5 | ANIKA THERAPEUTICS INC | ANIK | 1,081,360 | $20.1M | 9.25% |
| 6 | EXELIXIS INC | EXEL | 910,730 | $19.9M | 9.14% |
| 7 | EVOLUS INC | EOLS | 1,683,836 | $15.4M | 7.07% |
| 8 | VERONA PHARMA PLC | 925050106 | 183,064 | $3.0M | 1.37% |
| 9 | ADMA BIOLOGICS INC | ADMA | 597,513 | $2.1M | 0.98% |
| 10 | VERRICA PHARMACEUTICALS INC | VRCA | 259,593 | $1.0M | 0.46% |
| 11 | SOCIETAL CDMO INC | 75629F109 | 1,689,768 | $794,191 | 0.36% |
| 12 | Y-MABS THERAPEUTICS INC | 984241109 | 23,321 | $127,099 | 0.06% |
| 13 | AGIOS PHARMACEUTICALS INC | AGIO | 4,833 | $119,617 | 0.05% |